Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.7.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents $ 186,823 $ 21,398
Securities available-for-sale 845  
Accounts receivable 49 48
Accounts receivable due from related parties 2,602 1,333
Prepaid expenses and other current assets 4,219 1,964
Total current assets 194,538 24,743
Property, plant and equipment, net 25,518 10,993
Goodwill 1,190 1,190
Note receivable due from related party 251 251
Other non-current assets 2,421 1,901
Total assets 223,918 39,078
Current liabilities:    
Accounts payable and accrued liabilities 19,634 24,403
Accounts payable due to related parties 323 323
Total current liabilities 19,957 24,726
Embedded derivative   8,753
Commitments and contingencies (Note 6)
Stockholders' equity:    
Common stock: par value $0.01 and $0.001 per share, respectively; 300,000 shares and 200,000 shares authorized, respectively: 203,915 shares and 109,609 shares issued, respectively 1,874 101
Treasury stock: 1,231 and zero shares, respectively, at cost (323)  
Additional paid-in capital 440,419 102,148
Accumulated other comprehensive loss (60)  
Accumulated deficit (238,004) (96,655)
Total stockholders' equity 203,961 5,599
Total liabilities and stockholders' equity 223,918 39,078
Series A Preferred Stock [Member]    
Stockholders' equity:    
Convertible preferred stock   $ 5
Series B Preferred Stock [Member]    
Stockholders' equity:    
Convertible preferred stock $ 55